Other specified psychoactive substance dependence (Q40558): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Dependência de outra substância psicoativa especificada é um transtorno de regulação do uso de uma substância especificada que surge do uso repetido ou contínuo da substância especificada. O elemento característico é um forte impulso interno para usar a substância especificada, que é manifestado por capacidade prejudicada de controlar o uso, aumento da prioridade dada ao uso em detrimento de outras atividades, e persistência do uso apesar de danos ou consequências negativas. Essas experiências são frequentemente acompanhadas de uma sensação subjetiva de urgência ou fissura para usar a substância especificada. Aspectos fisiológicos da dependência também podem estar presentes, incluindo tolerância aos efeitos da substância especificada, sintomas de abstinência após a cessação ou redução no uso da substância especificada, ou uso repetido da substância especificada ou substâncias farmacologicamente semelhantes para prevenir ou aliviar os sintomas de abstinência. As manifestações da dependência geralmente são evidentes durante um período de pelo menos 12 meses, mas o diagnóstico pode ser feito se o uso da substância especificada for contínuo (diário ou quase diário) por pelo menos 3 meses. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Other specified psychoactive substance dependence is a disorder of regulation of use of a specified substance arising from repeated or continuous use of the specified substance. The characteristic feature is a strong internal drive to use the specified substance, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use the specified substance. Physiological features of dependence may also be present, including tolerance to the effects of the specified substance, withdrawal symptoms following cessation or reduction in use of the specified substance, or repeated use of the specified substance or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if use of the specified substance is continuous (daily or almost daily) for at least 3 months. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1934475925 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:6C4E.2 | |||||||||||||||
| Property / CURIE: CID11:6C4E.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-6C4E.2 | |||||||||||||||
| Property / Canary Token: dki-india-6C4E.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: F19.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 06:25, 13 August 2026
Other specified psychoactive substance dependence is a disorder of regulation of use of a specified substance arising from repeated or continuous use of the specified substance. The characteristic feature is a strong internal drive to use the specified substance, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use the specified substance. Physiological features of dependence may also be present, including tolerance to the effects of the specified substance, withdrawal symptoms following cessation or reduction in use of the specified substance, or repeated use of the specified substance or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if use of the specified substance is continuous (daily or almost daily) for at least 3 months.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C4E.2 |
||
| English | Other specified psychoactive substance dependence |
Other specified psychoactive substance dependence is a disorder of regulation of use of a specified substance arising from repeated or continuous use of the specified substance. The characteristic feature is a strong internal drive to use the specified substance, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use the specified substance. Physiological features of dependence may also be present, including tolerance to the effects of the specified substance, withdrawal symptoms following cessation or reduction in use of the specified substance, or repeated use of the specified substance or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if use of the specified substance is continuous (daily or almost daily) for at least 3 months. |
Statements
CID11:6C4E.2
0 references
dki-india-6C4E.2
0 references
Concluído
0 references
13 August 2026
0 references
